Genetic screening of a Dutch population with isolated GH deficiency (IGHD)

Clinical Endocrinology

Volumn 70, Issue 5, 2009, Pages 742-750

  De Graaff, Laura C G ^a,b   Argente, Jesús ^c,d   Veenma, Danielle C M ^a,b   Herrebout, Maaike A C ^e   Friesema, Edith C H ^e   Uitterlinden, André G ^e   Drent, Madeleine L ^f   Campos Barros, Ángel ^c   Hokken Koelega, Anita C S ^a,b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b Dutch Growth Foundation   (Netherlands)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR;

ARTICLE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RELEASE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANIMALS; BODY HEIGHT; CERCOPITHECUS AETHIOPS; CHILD, PRESCHOOL; COHORT STUDIES; COS CELLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETIC VARIATION; HETEROZYGOTE; HUMAN GROWTH HORMONE; HUMANS; INFANT; MALE; MUTATION; NETHERLANDS; PHENOTYPE; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 63149111500     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03414.x     Document Type: Article

References (28)

1. Lacey, K.A. Parkin, J.M. (1974) Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet, 1, 42 45.
2. Lindsay, R., Feldkamp, M., Harris, D. et al. (1994) Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. Journal of Pediatrics, 125, 29 35.
3. Thomas, M., Massa, G., Craen, M. et al. (2004) Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001. European Journal of Endocrinology, 151, 67 72.
4. Vimpani, G.V., Vimpani, A.F., Lidgard, G.P. et al. (1977) Prevalence of severe growth hormone deficiency. British Medical Journal, 2, 427 430.
5. Perez Jurado, L.A. Argente, J. (1994) Molecular basis of familial growth hormone deficiency. Hormone Research, 42, 189 197.
6. Pfaeffle, R.W. Blum, W.F. (2000) Understanding the Genetics of Growth Hormone Deficiency - a Reference Guide. TMG Healthcare Communications, Oxfordshire.
7. Fofanova, O.V., Evgrafov, O.V., Polyakov, A.V. et al. (2003) A novel IVS2-2A>T splicing mutation in the GH-1 gene in familial isolated growth hormone deficiency type II in the spectrum of other splicing mutations in the Russian population. Journal of Clinical Endocrinology and Metabolism, 88, 820 826.
8. Miyata, I., Cogan, J.D., Prince, M.A. et al. (1997) Detection of growth hormone gene defects by dideoxy fingerprinting (ddF). Endocrine Journal, 44, 149 154.
9. Ogawa, M., Kamijo, T., Igarashi, Y. et al. (2000) Prevalence of GH-1 gene deletion in patients with isolated growth hormone deficiency in Japan. GH Gene Study Group. Endocrine Journal, 47, 157 162.
10. Osorio, M.G., Marui, S., Jorge, A.A. et al. (2002) Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. Journal of Clinical Endocrinology and Metabolism, 87, 5076 5084.
11. Wagner, J.K., Eble, A., Hindmarsh, P.C. et al. (1998) Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatric Research, 43, 105 110.
12. Rikken, B., van, D.J., Ringeling, A. et al. (1998) Plasma levels of insulin-like growth factor (IGF) -I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Hormone Research, 50, 166 176.
13. Massa, G.G., Binder, G., Oostdijk, W. et al. (1998) De novo mutations of the growth hormone gene: an important cause of congenital isolated growth hormone deficiency? European Journal of Pediatrics, 157, 272 275.
14. Mullis, P.E., Robinson, I.C., Salemi, S. et al. (2005) Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study. Journal of Clinical Endocrinology and Metabolism, 90, 2089 2096.
15. Cartegni, L., Chew, S.L. Krainer, A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics, 3, 285 298.
16. Wang, M. Marin, A. (2006) Characterization and prediction of alternative splice sites. Gene, 366, 219 227.
17. Wajnrajch, M.P., Gertner, J.M., Mullis, P.E. et al. (2000) Arg183His, a new mutational hot-spot in the growth hormone gene causing isolated GH deficiency type II. Journal of Endocrine Genetics, 1, 124 134.
18. Dobson-Stone, C., Cox, R.D., Lonie, L. et al. (2000) Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. European Journal of Human Genetics, 8, 24 32.
19. Ellis, L.A., Taylor, C.F. Taylor, G.R. (2000) A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning. Human Mutation, 15, 556 564.
20. Gross, E., Arnold, N., Goette, J. et al. (1999) A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Human Genetics, 105, 72 78.
21. Jones, A.C., Austin, J., Hansen, N. et al. (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clinical Chemistry, 45, 1133 1140.
22. Liu, W.O., Oefner, P.J., Qian, C. et al. (1997) Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Genetic Testing, 1, 237 242.
23. O'Donovan, M.C., Oefner, P.J., Roberts, S.C. et al. (1998) Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics, 52, 44 49.
24. Binder, G., Keller, E., Mix, M. et al. (2001) Isolated GH deficiency with dominant inheritance: new mutations, new insights. Journal of Clinical Endocrinology and Metabolism, 86, 3877 3881.
25. Salemi, S., Yousefi, S., Baltensperger, K. et al. (2005) Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion. European Journal of Endocrinology, 153, 791 802.
26. Castro-Feijoo, L., Quinteiro, C., Campbell, J. (2004) [Combined treatment with GnRH analogues and GH]. Anales de Pediatría (Barcelona), 60 (Suppl. 2 15 23. (article in Spanish).
27. Moseley, C.T., Mullis, P.E., Prince, M.A. et al. (2002) An exon splice enhancer mutation causes autosomal dominant GH deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 847 852.
28. Millar, D.S. Lewis, M.D. Horan, M. et al. (2003) Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature. Human Mutation, 21, 424 440.